Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 2Breast Neoplasms 2Uterine Cervical Dysplasia 1Sarcoma 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Leukemia 1Insulin Resistance 1Diabetes Mellitus 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Cardiotoxicity 1Burns 1

Interventions

Cholecalciferol 4Nutrition Assessment 3Exercise 3Blood Pressure 3Atorvastatin 3acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Vitamin E 2Vitamin D 2Rosuvastatin Calcium 2Methods 2Metformin 2Gonadotropin-Releasing Hormone 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Educational Status 2Diet, Mediterranean 2Aspirin 2xinmailong 1sofosbuvir-velpatasvir drug combination 1pembrolizumab 1palbociclib 1ficlatuzumab 1beta Carotene 1amlodipine, atorvastatin drug combination 1Vorinostat 1Vitamin B 6 1Vitamin B 12 1Tumor Necrosis Factor Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cardiovascular Diseases × Fenofibrate × Clear all
NCT00884819 2015-04-03

Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Terminated
4 enrolled

Cardiovascular Diseases, Diabetes Mellitus, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡